Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index

Medicine (United States)

Volumn 94, Issue 12, 2015, Pages e654-

  Chung, Goh Eun ^a   Choi, Su Yeon ^a   Kim, Donghee ^a   Kwak, Min Sun ^a   Park, Hyo Eun ^a   Kim, Min Kyung ^a   Yim, Jeong Yoon ^a  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VESSEL PARAMETERS; BODY MASS; CARDIOANKLE VASCULAR INDEX; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHONOCARDIOGRAPHY; PHYSIOLOGY; PULSE RATE; SEVERITY OF ILLNESS INDEX;

BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PHONOCARDIOGRAPHY; PULSE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 84926612248     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000654     Document Type: Article

References (46)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis in adults Aliment Pharmacol Ther. 2011; 34:274-285
2. Choi SY, Kim D, Kim HJ, et al. The relation between non-Alcoholic fatty liver disease and the risk of coronary heart disease in Koreans Am J Gastroenterol. 2009; 104:1953-1960
3. Bae JC, Cho YK, Lee WY, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects Am J Gastroenterol. 2010; 105:2389-2395
4. Almeda-Valdes P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-Alcoholic fatty liver disease Ann Hepatol. 2009; 8 (suppl 1):S18-S24
5. Chen SH, He F, Zhou HL, et al. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011; 12:125-130
6. Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep. 2008; 10:73-80
7. Choi SY, Kim D, Kang JH, et al. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-Alcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol. 2008; 14:77-88
8. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-Alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia. 2008; 51:1947-1953
9. Kim D, Choi SY, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012; 56:605-613
10. Bhatia LS, Curzen NP, Byrne CD. Nonalcoholic fatty liver disease and vascular risk. Curr Opin Cardiol. 2012; 27:420-428
11. Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010; 51:595-602
12. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113:657-663
13. Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure Am J Hypertens. 2004; 17:39S-48S
14. Scuteri A, Cunha PG, Rosei EA, et al Arterial stiffness and influences of the metabolic syndrome: a cross-countries study Atherosclerosis. 2014; 233:654-660
15. Lee YJ, Shim JY, Moon BS, et al. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci. 2012; 57:196-203
16. Yu KJ, Zhang MJ, Li Y, et al. Increased whole blood viscosity associated with arterial stiffness in patients with non-Alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29:540-544
17. Huang RC, Beilin LJ, Ayonrinde O, et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology. 2013; 58:1306-1314
18. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27:2588-2605
19. Shirai K, Hiruta N, Song M, et al. Cardio-Ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011; 18:924-938
20. Shirai K, Utino J, Otsuka K, et al A novel blood pressureindependent arterial wall stiffness parameter; cardio-Ankle vascular index (CAVI). J Atheroscler Thromb. 2006; 13:101-107
21. Kubozono T, Miyata M, Ueyama K, et al. Clinical significance and reproducibility of new arterial distensibility index. Circ J. 2007; 71:89-94
22. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-Ankle vascular index is superior to brachial-Ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res. 2008; 31:1347-1355
23. Nakamura K, Tomaru T, Yamamura S, et al. Cardio-Ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008; 72:598-604
24. Miyoshi T, Doi M, Hirohata S, et al. Cardio-Ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb. 2010; 17:249-258
25. Zhang C, Ohira M, Iizuka T, et al. Cardio-Ankle vascular index relates to left ventricular ejection fraction in patients with heart failure A retrospective study. Int Heart J. 2013; 54:216-221
26. Okura T, Watanabe S, Kurata M, et al. Relationship between cardioankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007; 30:335-340
27. Suzuki J, Sakakibara R, Tomaru T, et al. Stroke and cardio-Ankle vascular stiffness index. J Stroke Cerebrovasc Dis. 2013; 22:171-175
28. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-1847
29. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002; 123:745-750
30. Park HE, Choi SY, Kim HS, et al. Epicardial fat reflects arterial stiffness: assessment using 256-slice multidetector coronary computed tomography and cardio-Ankle vascular index. J Atheroscler Thromb. 2012; 19:570-576
31. Salvi P, Ruffini R, Agnoletti D, et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens. 2010; 28:1699-1707
32. Vlachopoulos C, Manesis E, Baou K, et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study Am J Hypertens. 2010; 23:1183-1189
33. Sunbul M, Agirbasli M, Durmus E, et al Arterial stiffness in patients with non-Alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness Atherosclerosis. 2014; 237:490-493
34. VanWagner LB1, Ning H, Lewis CE3, et al Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-Aged adults: the Coronary Artery Risk Development in Young Adults Study Atherosclerosis. 2014; 235:599-605
35. Tarantino G1, Finelli C, Colao A, et al Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-Transferase?. J Transl Med. 2012; 10:50
36. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003; 41:183-187
37. Liang YL, Shiel LM, Teede H, et al. Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension. 2001; 37:6-11
38. Yu XY, Zhao Y, Song XX, et al Association between non-Alcoholic fatty liver disease and arterial stiffness in the non-obese, nonhypertensive, and non-diabetic young and middle-Aged Chinese population. J Zhejiang Univ Sci B. 2014; 15:879-887
39. Fang FS, Liu MY, Cheng XL, et al. Insulin resistance correlates with the arterial stiffness before glucose intolerance. Intern Med. 2014; 53:189-194
40. Webb DR, Khunti K, Silverman R, et al. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia. 2010; 53:1190-1198
41. Kern PA, Ranganathan S, Li C, et al Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab. 2001; 280:E745-E751
42. Targher G, Arcaro G. Non-Alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis. 2007; 191:235-240
43. Sookoian S, Castano GO, Burgueno AL, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease Atherosclerosis. 2010; 209:585-591
44. Sanyal AJ AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123:1705-1725
45. The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013; 19:325-348
46. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-Alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012; 142:1592-1609